Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Assets Average (2016 - 2025)

Historic Assets Average for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q3 2025 value amounting to $369.5 million.

  • Ironwood Pharmaceuticals' Assets Average fell 587.55% to $369.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.5 million, marking a year-over-year decrease of 587.55%. This contributed to the annual value of $411.0 million for FY2024, which is 4769.76% down from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Assets Average is $369.5 million, which was down 587.55% from $335.1 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Assets Average registered a high of $1.1 billion during Q1 2023, and its lowest value of $335.1 million during Q2 2025.
  • In the last 5 years, Ironwood Pharmaceuticals' Assets Average had a median value of $579.3 million in 2021 and averaged $710.0 million.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Assets Average skyrocketed by 12295.9% in 2021, and later plummeted by 5966.43% in 2024.
  • Ironwood Pharmaceuticals' Assets Average (Quarter) stood at $1.1 billion in 2021, then dropped by 2.97% to $1.1 billion in 2022, then crashed by 53.52% to $497.6 million in 2023, then fell by 25.6% to $370.2 million in 2024, then decreased by 0.19% to $369.5 million in 2025.
  • Its Assets Average stands at $369.5 million for Q3 2025, versus $335.1 million for Q2 2025 and $339.1 million for Q1 2025.